Shanghai Realbio Technology Co., Ltd.
PrivateLast Round
Series A
Extension
Apr 18, 2019
Total Funding Raised
$30.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Shanghai Realbio Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A Extension round in April 2019.
Shanghai Realbio Technology Co., Ltd. is a biotechnology company that specializes in microbiome genomics, gut health solutions, and precision tumor detection services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Realbio Technology Co., Ltd. Comparables
Compare Shanghai Realbio Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mapmygenome | 77% | |
| BaseClear B.V. | 77% | |
| OraSure Technologies Inc | 76% |
For institutional investors. Book with your work email.
Shanghai Realbio Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 18, 2019 | ||||
| Series A | Sep 21, 2017 | ||||
| Pre Seed | Oct 1, 2016 |
For institutional investors. Book with your work email.
Shanghai Realbio Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Marathon Venture Partners | Series A |
| Wuxi High-tech Zone Venture Capital Holding Group | Series A Extension |
| 松禾资本 (Green Pine Capital Partners) | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 71% MoM, from 614 to 1.1K.
- Apr 18, 2019
$15M round with Wuxi High-tech Zone Venture Capital Holding Group.
For institutional investors. Book with your work email.
Shanghai Realbio Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Realbio Technology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Realbio Technology Co., Ltd. a public or private company?
Shanghai Realbio Technology Co., Ltd. is a private company.
What is the current stock price of Shanghai Realbio Technology Co., Ltd.?
Shanghai Realbio Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Realbio Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Realbio Technology Co., Ltd. worth (valuation)?
Valuation information for Shanghai Realbio Technology Co., Ltd. is not publicly available.
Can I buy Shanghai Realbio Technology Co., Ltd. stock?
Shanghai Realbio Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Realbio Technology Co., Ltd.'s last funding round?
Shanghai Realbio Technology Co., Ltd.'s most recent funding round was Series A Extension on April 18, 2019.
Who are the main investors in Shanghai Realbio Technology Co., Ltd.?
Key investors in Shanghai Realbio Technology Co., Ltd. include Marathon Venture Partners, 松禾资本 (Green Pine Capital Partners).
Will Shanghai Realbio Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Realbio Technology Co., Ltd..
How can I track Shanghai Realbio Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Realbio Technology Co., Ltd.'s shares on secondary markets.